MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial for Major Depressive Disorder
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase I/IIa clinical trial for its lead product, SPL026,
MHRA approve the launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of opioid use disorder
MAC are excited to be collaborating with DemeRx on their phase 1 trial of Opioid Use Disorder.
High blood pressure may not cause obvious symptoms when you are young, but it should not be ignored. Some symptoms could include shortness of breath, headaches and chest